ARCHIVES

PFS Is A Benefit “In The Right Context,” Pazdur Says In Q&A On Avastin Approval.

This article is from The Cancer Letter archive.

Vol. 34 No. 08 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: Ahoy! It’s “Admiral Rick”

April 2, 1999

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

List of core grants renewed in FY 2003, full list of center grants.

January 16, 2004

ImClone Founding CEO Samuel Waksal Charged With Securities Fraud, Conspiracy, Perjury

June 14, 2002

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

May 21, 1982